Form 4: RxSight COO Ilya Goldshleger Exercises Stock Options

RxSight Chief Operating Officer Ilya Goldshleger exercised options to acquire 12,489 shares of common stock.

Summary

• Ilya Goldshleger, Chief Operating Officer of RxSight, Inc., exercised stock options for 12,489 shares of common stock.
• The transaction occurred on April 17, 2026, at an exercise price of $4.13 per share.
• Following the transaction, the reporting person directly owns 78,180 shares of common stock.
• The reporting person also maintains an indirect interest in 1,372 shares held by a spouse.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, representing standard executive equity management rather than a signal of market sentiment.

Positives

• The exercise of options by a key executive demonstrates continued alignment with the company's long-term equity performance.

Negatives

• None noted; this is a routine disclosure of executive equity activity.

Risks

• None noted.

Future Outlook

Not applicable; this is a retrospective disclosure of an equity transaction.

Industry Context

StockSavvy.ai notes that routine option exercises by C-suite executives are standard corporate governance practices and generally do not signal a change in strategic direction or material non-public information.

Comparison to Industry Standards

• The transaction follows standard SEC reporting requirements for executive equity movements.
• The exercise price of $4.13 reflects historical grant pricing typical for long-term incentive plans in the medical device sector.

Stakeholder Impact

• Minimal impact on shareholders as this is a routine exercise of existing equity compensation.

Next Steps

• No future actions or milestones were disclosed in this filing.

Key Dates

Keywords

RxSight, RXST, Insider Trading, Form 4, Executive Compensation, Stock Options